# Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)

> **NCT00392756** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 624 (actual)

## Conditions studied

- Kallmann Syndrome
- Hypogonadotropic Hypogonadism
- GnRH Deficiency

## Interventions

- **DRUG:** gonadotropin releasing hormone (GnRH)

## Key facts

- **NCT ID:** NCT00392756
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1989-04
- **Primary completion:** 2019-05-16
- **Final completion:** 2019-05-16
- **Target enrollment:** 624 (ACTUAL)
- **Last updated:** 2022-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00392756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00392756, "Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00392756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*